4Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and managements of drug-induced QT prolongation and tor- sade de points. Am Heart J,2007,153:89. 被引量：1
5Yap AG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart ,2003,89 : 1363-1372. 被引量：1
7Node T,Shimizu W,Satomi K,et al.Classification and mechanism of Torsade de Pointes initiation in the patients with congenital long QT syndrome[J].Euro Heart J,2004,25:2 149. 被引量：1
8Adamantidis MM.Mechanisms of action of class Ⅲ anti-arrhythmia agents[J].Arch Mal Coeur Vaiss,1995,88 (1):33-40. 被引量：1
9Gury C,Canceil O,Iaria P.Antipsychotic drugs and cardiovascular safety:current studies of prolonged QT interval and risk of ventricular arrhythmia[J].Encephale,2000,26(6):62-72. 被引量：1
10Lehmann MH,Hardy S,Archibald D,et al.Sex difference in risk of torsade de pointes with d,l-sotalol[J].Circulation,1996,94(10):2535-2541. 被引量：1
1Havmoeller,R. ,Reinier,K. ,Teodorescu,C. , et al. Low rate of second- ary prevention ICDs in the general population: Multiple-year multiple- source surveillance of sudden cardiac death in the Oregon Sudden Un- expected Death Study [ J ]. Journal of cardiovascular electrophysiology, 2013,24( 1 ) :60 - 65. 被引量：1
4Thomson B. K. A. , Huang S. -H. S, Chan C, et al. Nocturnal home he- modialysis associates with improvement of electrocardiographic features linked to sudden cardiac death [ J 1. ASAIO Journal, 2014,60 ( 1 ) : 99 - 105. 被引量：1
